|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.96 EUR | +0.49% |
|
+10.37% | -29.50% |
| Apr. 23 | Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 |
Pharma Mar, S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was EUR 196.34 million compared to EUR 229.83 million a year ago. Net income was EUR 49.36 million compared to EUR 92.86 million a year ago.
Basic earnings per share from continuing operations was EUR 2.73 compared to EUR 5.14 a year ago. Diluted earnings per share from continuing operations was EUR 2.73 compared to EUR 5.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.50% | 545M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
PHARMA MAR, S.A. 
